Schwab Charles Investment Management Inc. grew its position in Phibro Animal Health Corp (NASDAQ:PAHC) by 7.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 146,967 shares of the company’s stock after purchasing an additional 9,745 shares during the period. Schwab Charles Investment Management Inc. owned approximately 0.37% of Phibro Animal Health worth $4,924,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in PAHC. Mckinley Capital Management LLC Delaware raised its holdings in shares of Phibro Animal Health by 1.6% during the 3rd quarter. Mckinley Capital Management LLC Delaware now owns 112,857 shares of the company’s stock valued at $4,181,000 after buying an additional 1,755 shares during the period. Allianz Asset Management GmbH increased its holdings in Phibro Animal Health by 2.3% during the 3rd quarter. Allianz Asset Management GmbH now owns 108,930 shares of the company’s stock worth $4,036,000 after purchasing an additional 2,465 shares during the last quarter. Principal Financial Group Inc. increased its holdings in Phibro Animal Health by 1.8% during the 3rd quarter. Principal Financial Group Inc. now owns 146,814 shares of the company’s stock worth $5,439,000 after purchasing an additional 2,617 shares during the last quarter. Municipal Employees Retirement System of Michigan increased its holdings in Phibro Animal Health by 65.9% during the 3rd quarter. Municipal Employees Retirement System of Michigan now owns 7,250 shares of the company’s stock worth $269,000 after purchasing an additional 2,880 shares during the last quarter. Finally, Russell Investments Group Ltd. increased its holdings in Phibro Animal Health by 7.6% during the 3rd quarter. Russell Investments Group Ltd. now owns 44,173 shares of the company’s stock worth $1,636,000 after purchasing an additional 3,105 shares during the last quarter. 48.07% of the stock is currently owned by institutional investors and hedge funds.
Shares of PAHC traded up $1.00 during mid-day trading on Friday, hitting $41.55. The stock had a trading volume of 111,240 shares, compared to its average volume of 107,532. The firm has a market cap of $1,629.74, a price-to-earnings ratio of 27.52, a PEG ratio of 2.88 and a beta of 0.93. The company has a current ratio of 3.12, a quick ratio of 1.75 and a debt-to-equity ratio of 1.82. Phibro Animal Health Corp has a fifty-two week low of $26.75 and a fifty-two week high of $41.65.
Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Monday, February 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.38 by $0.06. Phibro Animal Health had a return on equity of 40.49% and a net margin of 7.90%. The business had revenue of $205.90 million during the quarter, compared to analyst estimates of $194.90 million. During the same quarter in the previous year, the firm posted $0.39 EPS. The business’s revenue for the quarter was up 7.5% compared to the same quarter last year. sell-side analysts predict that Phibro Animal Health Corp will post 1.69 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 28th. Investors of record on Wednesday, March 7th were given a dividend of $0.10 per share. The ex-dividend date of this dividend was Tuesday, March 6th. This represents a $0.40 dividend on an annualized basis and a yield of 0.96%. Phibro Animal Health’s dividend payout ratio is currently 26.49%.
In other Phibro Animal Health news, insider Jack Bendheim sold 24,000 shares of the business’s stock in a transaction on Thursday, March 15th. The stock was sold at an average price of $40.05, for a total transaction of $961,200.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Daniel M. Bendheim sold 3,960 shares of the business’s stock in a transaction on Tuesday, March 6th. The stock was sold at an average price of $40.06, for a total value of $158,637.60. Following the transaction, the vice president now owns 3,860 shares of the company’s stock, valued at approximately $154,631.60. The disclosure for this sale can be found here. Insiders have sold a total of 276,056 shares of company stock valued at $10,495,260 in the last 90 days. Insiders own 51.88% of the company’s stock.
Several equities research analysts have issued reports on the company. Zacks Investment Research upgraded Phibro Animal Health from a “hold” rating to a “buy” rating and set a $41.00 price objective on the stock in a report on Thursday, February 8th. BidaskClub downgraded Phibro Animal Health from a “sell” rating to a “strong sell” rating in a report on Tuesday, December 12th. Credit Suisse Group lifted their price objective on Phibro Animal Health from $37.00 to $39.00 and gave the stock a “neutral” rating in a report on Tuesday, February 6th. Morgan Stanley lifted their price objective on Phibro Animal Health from $30.00 to $36.00 and gave the stock an “underweight” rating in a report on Wednesday, February 7th. Finally, ValuEngine upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Wednesday, February 28th. Three research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $38.20.
COPYRIGHT VIOLATION WARNING: “Schwab Charles Investment Management Inc. Boosts Stake in Phibro Animal Health Corp (PAHC)” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another website, it was stolen and reposted in violation of U.S. and international copyright and trademark legislation. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/04/07/phibro-animal-health-corp-pahc-shares-bought-by-schwab-charles-investment-management-inc.html.
Phibro Animal Health Profile
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.